# OnCo record nct07510815 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct07510815/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct07510815", "NCT07510815" ;
  schema:name "Dual-Target MSLN/FAP CAR-NK Cells for Pleural and Peritoneal Mesothelioma"@en ;
  schema:description "A phase 1/2 trial of EB-MF-CAR-NK-01, Fludarabine, Cyclophosphamide in mesothelioma, run by Beijing Biotech, now recruiting."@en ;
  schema:url <https://onco.cc/trials/nct07510815/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT07510815> ;
  onco:status "recruiting" ;
  onco:tag "ctgov-ingest" ;
  onco:phase "1/2" ;
  schema:startDate "2026-03-02" ;
  onco:cancers <https://onco.cc/cancers/mesothelioma/>, <https://onco.cc/cancers/peritoneal-mesothelioma/>, <https://onco.cc/cancers/pleural-mesothelioma/> ;
  onco:drugs <https://onco.cc/drugs/eb-mf-car-nk-01/>, <https://onco.cc/drugs/fludarabine/>, <https://onco.cc/drugs/cyclophosphamide/> .